Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...
A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Emirateswoman.com on MSN9h
Red light therapy? Here’s 6 devices that are worth trying at homeThe popular at-home red light therapy skincare treatment uses low-level wavelengths of red light to address various skin ...
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on FibroBiologics, Inc. (FBLG – Research Report). The ...
At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...
Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking ...
US Weekly on MSN22h
After Years of Trying, These Are My 25 Favorite Lotions for Dry SkinAround 30% of the population suffers from dry skin, and I’m definitely among them — especially in the brutally cold winter ...
As the seasons change, your skin-care routine might need to change too. Prevent and soothe dry, irritated winter skin with ...
Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Biogen (BIIB – Research Report) and keeping the price target at ...
Eli Lilly sued the Health Resources and Services Administration (HRSA) for allegedly blocking the pharma giant's proposal to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback